Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Nerve Tissue

Explore clinical trials studying Neoplasms, Nerve Tissue. Study availability and eligibility vary by location and protocol.

6,308 public trials 1,294 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Nerve Tissue trial results

Completed

A Study Comparing Treatment With 177Lu-DOTA0-Tyr3-Octreotate to Octreotide LAR in Patients With Inoperable, Progressive, Somatostatin Receptor Positive Midgut Carcinoid Tumours

NCT01578239

Conditions
Carcinoid Tumor of the Small Bowel, Neoplasms, Neoplasms by Histologic Type, +5 more
Locations
  • Cedars-Sinai Medical Center Samuel Oschin Cancer Center Los Angeles, California, United States
  • Stanford Cancer Center Palo Alto, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Northwestern Medical Faculty Foundation Chicago, Illinois, United States
View all 39 locations
View Trial Details
Completed

Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid Tumors

NCT02646748

Conditions
Adenocarcinoma, Breast Cancer, Breast Diseases, +59 more
Locations
  • University of California San Francisco Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • John Wayne Cancer Institute at Providence Saint John's Health Center Santa Monica, California, United States
  • Georgetown University Medical Center Lombardi CCC Washington D.C., District of Columbia, United States
  • Hematology-Oncology Associates of Treasure Coast Port Saint Lucie, Florida, United States
View all 17 locations
View Trial Details
Completed

Trial of Nivolumab in Combination With Ipilimumab in Subjects With Previously Untreated Metastatic Uveal Melanoma

NCT02626962

Conditions
Eye Diseases, Eye Neoplasms, Melanoma, +14 more
Locations
  • Hospital Son Espases Palma de Mallorca, Balearic Islands, Spain
  • ICO Hospitalet L'Hospitalet de Llobregat, Spain
  • H. Insular de Canarias Las Palmas de Gran Canaria, Spain
  • Hospital La Paz Madrid, Spain
View Trial Details
Completed

Study of Nivolumab (BMS-936558) Plus Ipilimumab Compared With Ipilimumab Alone in the Treatment of Previously Untreated, Unresectable, or Metastatic Melanoma

NCT01927419

Conditions
Melanoma, Metastatic Melanoma, Neoplasms, +11 more
Locations
  • San Francisco Oncology Associates San Francisco, California, United States
  • Orlando Health Inc Orlando, Florida, United States
  • University Of Louisville Medical Center, Inc., Dba Louisville, Kentucky, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
View all 21 locations
View Trial Details

Related conditions